Shanda Asset Management Holdings’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Shanda Asset Management Holdings’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,500	Closed	-$42K	–	44
2019 Q2	$42K	Hold	2,500	–	–	0.01%	33
2019 Q1	$42K	Hold	2,500	–	–	0.01%	51
2018 Q4	$29K	Hold	2,500	–	–	0.01%	50
2018 Q3	$100K	Hold	2,500	–	–	0.02%	37
2018 Q2	$71K	Hold	2,500	–	–	0.01%	51
2018 Q1	$38K	Hold	2,500	–	–	0.01%	38
2017 Q4	$82K	Hold	2,500	–	–	0.01%	44
2017 Q3	$59K	Hold	2,500	–	–	0.01%	38
2017 Q2	$14K	Hold	2,500	–	–	﹤0.01%	33
2017 Q1	$18K	Hold	2,500	–	–	﹤0.01%	34
2016 Q4	$10K	Hold	2,500	–	–	﹤0.01%	28
2016 Q3	$18K	Buy	+2,500	New	+$16.9K	﹤0.01%	25

Other funds holding MRNS

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

GPCM

Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

VMI

VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Shanda Asset Management Holdings's MRNS Position: Q3 2019 in Review

Shanda Asset Management Holdings sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q3 2019, closing a stake of 2,500 shares — an estimated $42K sold.

Shanda Asset Management Holdings first reported a position in MRNS in Q3 2016 and held it in 12 quarters. The position peaked at $100K in Q3 2018. 64 funds tracked by Wall St. Rank hold MRNS as of Q3 2019.

Shanda Asset Management Holdings reported no remaining Marinus Pharmaceuticals, Inc position as of Q3 2019 after selling out during the quarter.
Shanda Asset Management Holdings sold 2,500 Marinus Pharmaceuticals, Inc shares in Q3 2019, an estimated $42K.
Shanda Asset Management Holdings first reported a position in Marinus Pharmaceuticals, Inc in Q3 2016 and held it in 12 quarters.
Shanda Asset Management Holdings's Marinus Pharmaceuticals, Inc position peaked at $100K in Q3 2018.
64 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q3 2019.

Based on Shanda Asset Management Holdings's 13F filing for Q3 2019, filed 14 Nov 2019.